Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Lacas

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Cancer|October 5, 2020
Predictive classifier for intensive treatment of head and neck cancerKaveh Zakeri, Federico Rotolo, Benjamin Lacas, et al.
Oral Oncology|July 27, 2019
Role of chemotherapy in 5000 patients with head and neck cancer treated by curative surgery: A subgroup analysis of the meta-analysis of chemotherapy in head and neck cancerEtienne Dauzier, Benjamin Lacas, Pierre Blanchard, et al.
Clinical and Translational Radiation Oncology|December 22, 2021
Meta-analysis of chemotherapy in nasopharynx carcinoma (MAC-NPC): An update on 26 trials and 7080 patientsPierre Blanchard, Anne W M Lee, Alexandra Carmel, et al.
The Lancet. Healthy Longevity|May 17, 2024
Adapted EXTREME regimen in the first-line treatment of fit, older patients with recurrent or metastatic head and neck squamous cell carcinoma (ELAN-FIT): a multicentre, single-arm, phase 2 trialJoël Guigay, Hervé Le Caer, François-Régis Ferrand, et al.
The Lancet. Oncology|June 3, 2023
Role of chemotherapy in patients with nasopharynx carcinoma treated with radiotherapy (MAC-NPC): an updated individual patient data network meta-analysisClaire Petit, Anne Lee, Jun Ma, et al.
The Lancet. Oncology|August 1, 2017
Role of radiotherapy fractionation in head and neck cancers (MARCH): an updated meta-analysisBenjamin Lacas, Jean Bourhis, Jens Overgaard, et al.
The Lancet. Oncology|April 16, 2021
Chemotherapy and radiotherapy in locally advanced head and neck cancer: an individual patient data network meta-analysisClaire Petit, Benjamin Lacas, Jean-Pierre Pignon, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 30, 2021
Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 107 randomized trials and 19,805 patients, on behalf of MACH-NC GroupBenjamin Lacas, Alexandra Carmel, Cécile Landais, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 5, 2014
Genetic markers of toxicity from capecitabine and other fluorouracil-based regimens: investigation in the QUASAR2 study, systematic review, and meta-analysisDan Rosmarin, Claire Palles, David Church, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Cancer|October 5, 2020
Predictive classifier for intensive treatment of head and neck cancerKaveh Zakeri, Federico Rotolo, Benjamin Lacas, et al.
Oral Oncology|July 27, 2019
Role of chemotherapy in 5000 patients with head and neck cancer treated by curative surgery: A subgroup analysis of the meta-analysis of chemotherapy in head and neck cancerEtienne Dauzier, Benjamin Lacas, Pierre Blanchard, et al.
Clinical and Translational Radiation Oncology|December 22, 2021
Meta-analysis of chemotherapy in nasopharynx carcinoma (MAC-NPC): An update on 26 trials and 7080 patientsPierre Blanchard, Anne W M Lee, Alexandra Carmel, et al.
The Lancet. Healthy Longevity|May 17, 2024
Adapted EXTREME regimen in the first-line treatment of fit, older patients with recurrent or metastatic head and neck squamous cell carcinoma (ELAN-FIT): a multicentre, single-arm, phase 2 trialJoël Guigay, Hervé Le Caer, François-Régis Ferrand, et al.
The Lancet. Oncology|June 3, 2023
Role of chemotherapy in patients with nasopharynx carcinoma treated with radiotherapy (MAC-NPC): an updated individual patient data network meta-analysisClaire Petit, Anne Lee, Jun Ma, et al.
The Lancet. Oncology|August 1, 2017
Role of radiotherapy fractionation in head and neck cancers (MARCH): an updated meta-analysisBenjamin Lacas, Jean Bourhis, Jens Overgaard, et al.
The Lancet. Oncology|April 16, 2021
Chemotherapy and radiotherapy in locally advanced head and neck cancer: an individual patient data network meta-analysisClaire Petit, Benjamin Lacas, Jean-Pierre Pignon, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 30, 2021
Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 107 randomized trials and 19,805 patients, on behalf of MACH-NC GroupBenjamin Lacas, Alexandra Carmel, Cécile Landais, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 5, 2014
Genetic markers of toxicity from capecitabine and other fluorouracil-based regimens: investigation in the QUASAR2 study, systematic review, and meta-analysisDan Rosmarin, Claire Palles, David Church, et al.
Pageof 3